Accelerating Cardihab’s Commercialisation Journey with ANDHealth+

ANDHealth specialises in the acceleration of commercialisation of evidence-based digital health technologies through targeted programs and expert support. Their ANDHealth + Program funded by the Australian Government’s Medical Research Future Fund has opened for applications. ANDHealth Co-founder and Chief Product Officer Grace Lethlean explains how thisunique accelerator can be a gamechanger for those SMEs who are selected to share in up to $3.75M of project funding per intake. Cardihab is a digital health company focused on improving cardiac rehabilitation who was selected to take part in ANDHealth + in 2021. We find out from CEO Helen Souris all about the benefits of securing this funding and commercialisation support and her tips for digital health innovators thinking of applying.  Cardihab was also awarded funding through MTPConnect’s Targeted Translation Research Accelerator for Diabetes and Cardiovascular disease to develop their digital health therapeutic for heart failure. ANDHealth is a TTRA partner and has been supporting Cardihab with mentoring and commercialisation advice.Hosts are Caroline Duell, MTPConnect’s Director Media and Communications and Dr Mana Liao, MTPConnect’s Acting Senior Director, TTRA Program.Apply for ANDHealth + by 18 June 2023 at the ANDHealth website.